Literature DB >> 2382645

Isokinetic muscle strength predicts maximum exercise tolerance in renal patients on chronic hemodialysis.

W Diesel1, T D Noakes, C Swanepoel, M Lambert.   

Abstract

Patients with end-stage renal disease receiving chronic hemodialysis have impaired exercise tolerance. To distinguish between a central cardiorespiratory and a peripheral skeletal muscular origin for this fatigue, we measured exercise performance and peak oxygen consumption during a maximum exercise test in 10 patients receiving chronic hemodialysis. Skeletal muscle function was measured with an isokinetic cycle ergometer and a Cybex II isokinetic dynamometer. Peak rates of oxygen consumption (17.7 +/- 3.6 [mean +/- SD] mL O2/kg/min), blood lactate concentrations (3.4 +/- 0.9 mmol/L), peak heart rates (168 +/- 12 beats/min), and rates of ventilation (37.3 +/- 14.6 L/min) were low, but respiratory exchange ratios (1.1 +/- 0.1) were compatible with maximal effort. There was a significant correlation between isokinetic muscle strength and VO2 peak, exercise duration, peak ventilation, and peak blood lactate concentrations (P less than 0.05 to less than 0.001), but not between hemoglobin concentration, total blood hemoglobin content, or hematocrit and these variables. Therefore, in renal dialysis patients, isokinetic muscle strength is a better predictor of exercise capacity than are variables determining blood oxygen carrying capacity. This suggests that altered skeletal muscle function explains the impaired exercise tolerance of anemic patients with end-stage renal disease receiving chronic hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382645     DOI: 10.1016/s0272-6386(12)80563-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

2.  Exercise as an Adjunct Therapy In Chronic Kidney Disease.

Authors:  Danielle L Kirkman; David G Edwards; Shannon Lennon-Edwards
Journal:  Renal Nutr Forum       Date:  2014

3.  31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.

Authors:  G E Moore; L A Bertocci; P L Painter
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 4.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Oxygen delivery does not limit peak running speed during incremental downhill running to exhaustion.

Authors:  G Liefeldt; T D Noakes; S C Dennis
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

Review 6.  Central and peripheral adaptations to physical training in patients with end-stage renal disease.

Authors:  E J Kouidi
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 7.  Exercise and chronic kidney disease: current recommendations.

Authors:  Kirsten L Johansen
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 8.  Prehabilitation for the Frail Patient Approaching ESRD.

Authors:  Anoop Sheshadri; Kirsten L Johansen
Journal:  Semin Nephrol       Date:  2017-03       Impact factor: 5.299

9.  Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression.

Authors:  Emma L Watson; George C Kosmadakis; Alice C Smith; Joao L Viana; Jeremy R Brown; Karen Molyneux; Izabella Z A Pawluczyk; Michael Mulheran; Nicolette C Bishop; Susan Shirreffs; Ronald J Maughan; Paul J Owen; Stephen G John; Christopher W McIntyre; John Feehally; Alan Bevington
Journal:  Eur J Appl Physiol       Date:  2013-04-17       Impact factor: 3.078

10.  Effects of hemodialysis therapy on sit-to-walk characteristics in end stage renal disease patients.

Authors:  Rahul Soangra; Thurmon E Lockhart; John Lach; Emaad M Abdel-Rahman
Journal:  Ann Biomed Eng       Date:  2012-12-05       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.